Sikiric's lab in Croatia) No independent replication No competing research Raises red flags about bias Human data: ONE small retrospective study (not a randomized trial) No large-scale clinical trials No safety studies Unknown dosing Unknown side effects Recent systematic review (2024): Published in orthopaedic literature, concluded: "BPC-157 has potential based on preclinical data, but there is a concerning lack of published clinical trial data because studies appear to have been cancelled or stopped without publication." Reported Side Effects (From Online Users): Anonymous reports include: Injection site pain and swelling Joint pain Anxiety and panic attacks Heart palpitations Insomnia or drowsiness Fatigue and weakness Loss of appetite Depression and anhedonia (inability to feel pleasure) Note: These are anecdotal, not from clinical trials

Selection is decided at the $150 initial consultation based on labs, scalp evaluation, hair loss type (androgenetic, telogen effluvium, post-inflammatory, hormonal), and the patients overall goals
Yuan H, Perry CN, Huang C, Iwai-Kanai E, Carreira RS, Glembotski CC et al
KT LUN TINH CHT HU LOI NO TT